However, a considerable fraction of the tumors exhibited a higher expression of Spry1 to the corresponding peripheral tissue indicating that, although decreased Spry1 expression is seen in a substantial fraction of prostate cancers, loss of Spry1 expression is not required in all prostate cancers. This evidence concerns the gene SPRY1 and prostate carcinoma.